BioSante and speciality pharmaceuticals and contract manufacturing firm ANI Pharmaceuticals are merging in a stock-based merger that will combine the former’s cash, anticipated future licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results